Press "Enter" to skip to content

Exclusive Report on Ulcerative Colitis Market 2019 | Industry Drivers, Business Plans, Types, Applications, Challenges, Opportunities and Latest Trends Forecast to 2024

Ulcerative

The “Ulcerative Colitis Market” research report 2019 delivers comprehensive information about the market ranging from the establishment to the predictable growth trend. Ulcerative Colitis market report provides brief analytical data of the market contenders globally using advanced methodological approaches, such as SWOT analysis, production chain, cost, sales margin, financial details, recent developments. Ulcerative Colitis market report also offers market competitors that includes detailed company profiles along with company product specifications.

Market Overview:

  • The ulcerative colitis market was valued at USD 6,854.47 million in 2018, and is also expected to register a CAGR of 4.86% during the forecast period (2019-2024). Ulcerative colitis (UC) is the most common form of inflammatory bowel disease which affects several people. From a global perspective, several research studies in 2018 have reported annual incidence rates of UC ranging from 0.5 to 24.5 cases per 100,000 people. On the other hand, incidences have been increasing in Asian and South European countries. In the United States, UC affects an estimated 500,000 people and is the cause of 250,000 doctor visits and 30,000 hospitalizations, each year. UC has an uneven presence in major geographical regions across the world. It is common in most of Europe and North America and uncommon in most of the developing Asian countries. UC is more prevalent among males and has a regional north-to-south variation. One potential explanation is the differences in exposure to ultraviolet light, resulting in relative vitamin D deficiency in countries close to the Arctic. People who live in lower latitudes are more likely to develop UC than those in higher latitudes.
  • According to the Centers for Disease Control and Prevention (CDC), in 2015, 1.3% of US adults (3 million) reported that they were diagnosed with IBD (either Crohn’s disease or UC). This was a large increase in number from 1999 (0.9% or 2 million adults). According to an article published in PubMed, the highest reported prevalence values were in Europe (UC – 505 per 100,000 people in Norway, Crohn’s disease – 322 per 100,000 people in Germany) and North America (UC – 286 per 100,000 people in the United States, Crohn’s disease – 319 per 100,000 people in Canada). The high prevalence of the disease is driving the market.

    Get a Sample Copy of the Report – https://www.industryresearch.co/enquiry/request-sample/14098962

    In Ulcerative Colitis Market Report, Following Companies Are Covered:

  • AbbVie Inc.
  • Bausch Health Companies Inc. (Salix Pharmaceutical)
  • Boehringer Ingelheim GmbH
  • Johnson and Johnson
  • Merck & Co.
  • Novartis AG
  • Shire
  • Takeda Pharmaceuticals
  • Teva Pharmaceuticals Ltd
  • Pfizer Inc.

    Ulcerative Colitis Market 2019 report will help the industry aspirants in arranging their strategies. The measurements offered in this report will be an exact and helpful manual to shape the business development. Additionally, will Provide historical data along with a future forecast and detailed analysis and also expected opportunities.

    Scope of the Report:

  • As per the , ulcerative colitis is a chronic, inflammatory bowel disease that causes inflammation in the digestive tract. Treatment for ulcerative colitis includes medication and surgery. However, the scope of this report includes only medications for the ulcerative colitis disease.

    Reasons for Buying Ulcerative Colitis Market Report:

    • This report provides pin-point analysis for changing competitive dynamics
    • It provides a forward looking perspective on different factors driving or restraining market growth
    • It provides a five-year forecast assessed on the basis of how the market is predicted to grow
    • It helps in understanding the key product segments and their future
    • It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
    • It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments

    For More Information or Query or Customization Before Buying, Visit at – https://www.industryresearch.co/enquiry/pre-order-enquiry/14098962

    Key Market Trends:

    Ulcerative Proctitis Segment is Expected to Experience the Fastest Growth during the Forecast Period

    Ulcerative proctitis is one of the types of ulcerative colitis. It is considered as the initial manifestation of ulcerative colitis, in which fine ulcerations in the inner linings of mucosa of the large intestine are seen. A survey was conducted by NIH in 2016, to understand the prevalence of disease, which gave results, such as 25% of the pediatric patients surveyed had the disease, and 17 to 21% of the adult patients had ulcerative proctitis. As per this data obtained by the survey, NIH stated that there was a rise in the number of patients suffering from ulcerative proctitis, compared to the previous years. Hence, this segment, by disease type, is believed to experience growth in the future.

    North America Region Holds the Largest Market Share of the Ulcerative Colitis Market Currently and is Believed to Follow the Same Trend over the Forecast Period

    North America is expected to lead the ulcerative colitis market, owing to the presence of key players and increasing prevalence of the disease in the region, along with the continuing funding for the development of new therapeutics for the treatment of the condition.

    The Research Document Will Answer Following Questions Such as:

    • What are the cutting-edge technologies responsible for driving the growth of the market?
    • What are the main applications of the market? What are the growth prospects to the market applications into the market?
    • At what stage of development are the key market products?
    • What are the shortcomings that has to face to become commercially viable? Is their growth and commercialization dependent on cost declines or technological/application breakthroughs?
    • What is the outlook for the industry?
    • What difference does performance characteristics of Ulcerative Colitis create from those of established entities?

    Purchase this Report (Price 4250 USD for single user license) – https://www.industryresearch.co/purchase/14098962

    Detailed TOC of Ulcerative Colitis Market Report 2019-2024:

    1 INTRODUCTION
    1.1 Study Deliverables
    1.2 Study Assumptions
    1.3 Scope of the Study

    2 RESEARCH METHODOLOGY

    3 EXECUTIVE SUMMARY

    4 MARKET DYNAMICS
    4.1 Market Overview
    4.2 Market Drivers
    4.2.1 High Global Incidence and Prevalence of Ulcerative Colitis
    4.2.2 New Product Launches in the Market
    4.2.3 Increase in Patient Assistance Programs
    4.3 Market Restraints
    4.3.1 High Levels of Unmet Clinical Need in Ulcerative Colitis (UC)
    4.3.2 Side-effects of Medications
    4.4 Porter’s Five Forces Analysis
    4.4.1 Threat of New Entrants
    4.4.2 Bargaining Power of Buyers/Consumers
    4.4.3 Bargaining Power of Suppliers
    4.4.4 Threat of Substitute Products
    4.4.5 Intensity of Competitive Rivalry

    5 MARKET SEGMENTATION
    5.1 Drug Type
    5.1.1 Anti-Inflammatory Drugs
    5.1.1.1 Aminosalicylates
    5.1.1.2 Corticosteroids
    5.1.2 Anti-TNF biologics
    5.1.3 Immunosuppressant
    5.1.4 Calcineurin Inhibitors
    5.1.5 Other Drug Types
    5.2 By Disease Type
    5.2.1 Ulcerative Proctitis
    5.2.2 Proctosigmoiditis
    5.2.3 Left-sided Colitis
    5.2.4 Pancolitis or Universal Colitis
    5.2.5 Fulminant Colitis
    5.3 Geography
    5.3.1 North America
    5.3.1.1 US
    5.3.1.2 Canada
    5.3.1.3 Mexico
    5.3.2 Europe
    5.3.2.1 Germany
    5.3.2.2 UK
    5.3.2.3 France
    5.3.2.4 Italy
    5.3.2.5 Spain
    5.3.2.6 Rest of Europe
    5.3.3 Asia-Pacific
    5.3.3.1 China
    5.3.3.2 Japan
    5.3.3.3 India
    5.3.3.4 Australia
    5.3.3.5 South Korea
    5.3.3.6 Rest of Asia-Pacific
    5.3.4 Middle East & Africa
    5.3.4.1 GCC
    5.3.4.2 South Africa
    5.3.4.3 Rest of Middle East & Africa
    5.3.5 South America
    5.3.5.1 Brazil
    5.3.5.2 Argentina
    5.3.5.3 Rest of South America

    6 COMPETITIVE LANDSCAPE
    6.1 Company Profiles
    6.1.1 AbbVie Inc.
    6.1.2 Bausch Health Companies Inc. (Salix Pharmaceutical)
    6.1.3 Boehringer Ingelheim GmbH
    6.1.4 Johnson and Johnson
    6.1.5 Merck & Co.
    6.1.6 Novartis AG
    6.1.7 Shire
    6.1.8 Takeda Pharmaceuticals
    6.1.9 Teva Pharmaceuticals Ltd
    6.1.10 Pfizer Inc.

    7 MARKET OPPORTUNITIES AND FUTURE TRENDS

     

    Contact Us:

    Name: Ajay More

    Phone: US +14242530807/ UK +44 20 3239 8187

    Email: [email protected]

    Our Other Reports:

    Surgical Mesh Market Size 2019 Analysis By Industry Share, Emerging Demands, Growth Rate, Recent & Future Trends, Opportunity, and Forecast To 2024

    Electronic Films Market 2019 Global Industry Forecasts Analysis, Company Profiles, Competitive Landscape and Key Regions Analysis Available at Industry Research Biz

    Deep Well Pump Market 2019 Global Industry Size, Share, Forecasts Analysis, Company Profiles, Competitive Landscape and Key Regions 2023 Available at Industry Research.co

    Glass Sunroofs Market 2019 by Consumption Volume, Average Price, Revenue, Market Share and Trend to 2025

  • Be First to Comment

    Leave a Reply

    Your email address will not be published. Required fields are marked *